AASLD: Cirrhosis Patients Benefit from Anticoagulant (CME/CE)
(MedPage Today) — SAN FRANCISCO -– In people with advanced cirrhosis, a low molecular weight heparin can prevent portal vein thrombosis, a researcher said here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com